Status:
UNKNOWN
Bioavailability of Astaxanthin Formulations
Lead Sponsor:
Algatechnologies Ltd.
Conditions:
Healthy Volunteers
Eligibility:
All Genders
21-50 years
Phase:
EARLY_PHASE1
Brief Summary
Bioavailability of dietary supplement formulations in healthy volunteers after a single oral dose.
Detailed Description
Comparison of the bioavailability of 3 formulations with astaxanthin in healthy volunteers after single dose
Eligibility Criteria
Inclusion
- Subjects who have signed an informed consent form and who meet all of the following entrance criteria may be enrolled in this clinical trial: Generally, healthy men and women who are 21 to 50 years of age, inclusive, at the baseline visit.
Exclusion
- 1\. Are unwilling to follow the procedures of the trial, such as making visits or having their blood drawn.
- 2\. Have unintentionally lost or gained 10 or more kg of body weight in the last 3 months; 3. Have an acute illness (such as a severe cold or flu) or have been hospitalized within the past month for certain conditions; 4. Have severe co-morbid disease including cardiac, pulmonary, renal, hepatic, carotid, peripheral vascular disease, stroke, neurological, clotting disorders or active cancer; 5. Taking chronic drugs which interfere with lipids metabolism (statins or similar) 6. Consume alcohol at an elevated level (Defined as consumption of more than 10 standard alcoholic drinks per week. A standard alcoholic drink is defined as one bottle/can of beer or one glass of wine equals one portion of hard liquor).
- 7\. Consume carotenoids as food supplements. 8. Have a Body Mass Index (BMI) of less than 17 or greater than 35 m/kg2; 9. Have participated in a clinical trial in the past 4 weeks; 10. Have any disease or condition that in the investigator's opinion compromises the integrity of the clinical trial or the safety of the subject; 11. Smokers 12. Pregnant woman
Key Trial Info
Start Date :
March 25 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 30 2019
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT03443882
Start Date
March 25 2018
End Date
May 30 2019
Last Update
May 21 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bert W. Strassburger Lipid Center, Sheba Medical Center,
Tel Litwinsky, Israel, 52621